Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-21
1999-04-06
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544250, 544251, A61K 31505, C07D23900, C07D47100, C07D48700
Patent
active
058918825
ABSTRACT:
The present invention relates to a compound of the formula ##STR1## and the pharmaceutically acceptable salts thereof wherein W is a bicyclic heterocyclic ring system. The compounds are .alpha.-1 adrenergic antagonists and are useful in the treatment of BPH; also disclosed are .alpha.-1 antagonist compositions and a method for antagonizing .alpha.-1 adrenoreceptors and tr
REFERENCES:
patent: 3888946 (1975-06-01), Pars et al.
patent: 4117140 (1978-09-01), Brown et al.
patent: 4385056 (1983-05-01), Loozen
patent: 5387591 (1995-02-01), Lavielle et al.
patent: 5597823 (1997-01-01), Meyer et al.
Pars, H. G., et al., "Drugs Derived from Cannabinoids. 1. Nitrogen Analogs, Benzopyranopyridines and Benzopyranopyrroles", Journal of Medicinal Chemistry, 19(4):445-453 (1976).
Caine, et al., "Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder Neck", British Journal of Urology, 47:193-202 (1975.
Chapple, "Medical treatment for benigh prostatic hyperplasia", BMJ, 1198-1199 (1992).
Chapple, et al., "Characterisation of Human Prostatic Adrenoceptors using Pharmacology receptor Binding and Localisation", British Journal of Urology, 63:487-496 (1989).
Chapple, et al., "A Twelve-Week Placebo-Controlled Study of Prazosin in the Treatment of Prostatic Obstruction", Urol Int, 45(1):47-55 (1990).
Chow, et al,., "Multicentre Controlled Trail of Indoramin in the Symptomatic Relief of Benigh Prostatic Hypertrophy", British Journal of Urology, 65:36-38 (1990).
Gittes. et al., "Female Urethral Syndrome A Female Prostatitis?", WJM, 164(5):435-438 (1996).
Hoffman, et al., "Alpha Adrenergic Receptor Subtypes in Rabbit Uterus: Mediation of Myometrial Contraction and Regulation by Estrogens", The Journal of Pharmacology and Experimental Therapeutics, 219(2):290-295 (1981).
Janknegt, et al., "Efficacy and Safety of the Alpha-1 Blocker Doxazosin in the Treatment of Benigh Prostatic Hyperplasia", Eur Urol,24:319-326 (1993).
Lepor, "Alpha Blockade for the Treatment of Benigh Prostatic Hyperplasia", Urologic Clinics of North America, 22(2):375-386 (1995).
Miller, et al., "Uterine response to nerve stimulation; relation to hormonal status and catecholamines", American Journal of Physiology, 209:859-863 (1965).
Roberts, et al., Regulation of Myometrial Adrenoreceptors and Adrenergic Response by Sex Steroids:, Molecular Pharmacology, 20:52-58 (1981).
Rosier, et al., "Is Detrusor Instability in Elderly Males Related to the Grade of Obstruction?", Neurourology and Urodynamics, 14:625-633 (1995).
Thien, et al., "Urinary incontinence caused by prazosin", British Medical Journal, 622-623 (1978).
Altenbach Robert J.
Basha Fatima Z.
Carroll William A.
Drizin Irene
Kerwin, Jr. James F.
Abbott Laboratories
Kifle Bruck
Raymond Richard L.
Ward Michael J.
LandOfFree
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1371607